Table 4 Presentation and neurological manifestations among patients with mucormycosis.
From: COVID-19 associated mucormycosis in Assiut University Hospitals: a multidisciplinary dilemma
N = 33 | |
|---|---|
Presentation | |
Rhino orbital | 1 (3.03%) |
Rhino orbital cerebral | 32 (96.96%) |
Neurological manifestions | |
Headache | 28 (84.84%) |
Nerve palsy (3rd, 4th, 5th, 6th) | 27 (81.81%) |
Periorbital swelling/proptosis | 26 (78.78%) |
Hemiparesis | 3 (9.09%) |
Diminution/loss of vision | 25 (75.75%) |
